https://www.businesswire.com/news/home/20191120005795/en/

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Nov 20, 2019--

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 2:30 p.m. EST in New York City.